Healthtech Startups

Inventum Biotech develops software solutions for analytical, multimodal, and AI-based applications focused on preventing and managing non-communicable diseases using data and analytics.

1 investor

Gallant develops regenerative medicine for pets using allogeneic mesenchymal stromal cell (MSC) therapies, with a pipeline targeting conditions such as feline chronic gingivostomatitis, feline and canine osteoarthritis, feline chronic kidney disease, and canine atopic dermatitis. Its ready-to-use, intravenously administered therapies follow the FDA approval process and are offered to veterinarians and pet families across the U.S.

1 investor

Galvanize Therapeutics develops surgical ablation technology using its proprietary Aliya Pulsed Electric Field (PEF) energy to destroy soft tissue cells through regulated cell death mechanisms. Its products serve clinical fields such as interventional pulmonology and thoracic surgery.

1 investor

Galventa develops delivery technologies for food supplements and over-the-counter products designed to optimize dosage timing and bioavailability. The company focuses on improving the efficacy of nutraceutical formulations through galenic innovation.

1 investor

Gamida Cell develops cell therapy treatments designed to expand and enhance cells for therapeutic applications. The company focuses on delivering potentially curative therapies to patients with unmet medical needs.

1 investor

Gamma Diagnostics develops diagnostic tests based on Gamma Prime Fibrinogen (GPF), a blood biomarker for assessing inflammation and predicting cardiovascular and infectious disease outcomes. The company serves clinicians and healthcare providers seeking improved patient risk stratification and treatment planning.

1 investor

GammaTile is an FDA-cleared, bioresorbable collagen tile embedded with radiation sources that is implanted during brain tumor removal surgery to deliver targeted radiation to remaining cancer cells. It is indicated for patients with operable, newly diagnosed and recurrent brain tumors such as glioblastoma, brain metastases, and meningiomas.

1 investor

Gamow Labs builds an AI system that interprets whole genomes and clinical phenotypes to identify causative variants and produce ACMG-style clinical reports with auditable evidence and treatment recommendations. It serves clinical genetics workflows, focusing on genome interpretation and diagnosis of rare/hard cases.

1 investor

Gan & Lee appears to be a company with significant revenue (4.052 billion reported) and R&D investment activity (1.341 billion CNY), but the page visited does not contain clear information about its core business operations, products, or market focus.

1 investor

Gardens for Health International addresses childhood malnutrition in Rwanda through an agriculture-based model, providing families with nutrition education, seeds, livestock, and gardening resources alongside programs for schools and early childhood development centers. It also runs village savings and loan groups and maternal and child nutrition programs to build long-term food security for rural families.

1 investor

Garland Surgical develops the TriActiv Hip (formerly MaltaHip), a total hip replacement implant using a patented tri-axial design intended to improve mobility, stability, and durability while reducing revision surgeries. Aimed at orthopaedic surgeons and hip arthroplasty patients, the company plans to commercialize the device through OEM licensing, with an initial US market entry via FDA 510(k).

1 investor

Garnet Healthcare partners with healthcare providers to adopt and operate remote and virtual care programs, including remote patient monitoring (RPM/RTM), chronic care management, transitional care, and hospital-at-home, through a co-sourced Care Integration Center with accredited staffing and technology. It also offers wellness programs for self-funded employers.

1 investor

Gasgon Medical develops fluid management devices for the clinical market, including AirVault, a single-use device that removes air bubbles from IV fluids. The company builds tools to improve IV infusion for patients and clinicians in healthcare settings.

1 investor

Gastfreund offers a modular guest experience platform with a guest app, information channel, and team communication tools (Hotelboard) for hotels, resorts, campsites and vacation rentals as well as healthcare and care facilities such as hospitals, rehab and senior residences. The platform centralizes stay-related information, automates recurring tasks, and supports guest and staff communication with auto-translation.

1 investor

Gastrocare Partners operates a network of gastrointestinal practices in the western United States, bringing together established clinical practices to enable collaborative care and advanced interventional endoscopic treatments.

1 investor

Gastro Health is a medical group of board-certified physicians and advanced practitioners specializing in gastrointestinal disorders, nutrition, and digestive health. The group provides comprehensive care including evaluation, treatment, surgery, colorectal procedures, infusion services, diagnostic studies, nutrition therapy, and weight loss programs.

1 investor

Gastroenterology Consultants of San Antonio is a gastroenterology medical practice serving patients in South Texas. Its GI physicians provide diagnosis and treatment for digestive and gastrointestinal conditions.

1 investor

The Bill & Melinda Gates Foundation is a philanthropic organization that funds research, programs, and initiatives addressing global health, development, and education challenges, particularly affecting low-income populations in developing countries.

1 investor

Gather Group builds a platform that coordinates personal care teams—family, friends, and caregivers—to support patients through care transitions and help them enact their recovery plans. The platform targets hospitals, GPs, and rehabilitation facilities seeking to improve patient outcomes by shifting care coordination from individual self-management to a team-based approach.

1 investor

Gavi is a public-private partnership that funds vaccination programs in developing countries through contributions from governments, foundations, corporations, and private donors. The organization mobilizes resources to provide vaccine access and shape vaccine markets in supported nations.

1 investor

Seattle's LGBTQ+ Center is a community organization providing health services, wellness programs, arts initiatives, and resource navigation for LGBTQ individuals in the Seattle area. The center operates as a hub offering HIV/STI testing, PrEP navigation, healthcare support, youth programs, and cultural programming.

1 investor

GBI Biomanufacturing manufactures stem cells for regenerative medicine applications, including treatments for orthopedic injuries, wound care, and arthritic conditions. The company operates a 40,000-square-foot facility in Plantation, Florida and has expanded its stem-cell production capacity to serve growing demand driven by new state legislation permitting broader clinical use of stem-cell therapies.

1 investor

CcHUB Growth Capital is an early-stage venture fund investing between ₦10 million and ₦30 million in seed and early-stage for-profit technology startups building solutions to local challenges in Nigeria. It provides funding, business advisory, and network connections to help portfolio companies scale and attract follow-on funding.

1 investor

A South Korean developer of biopharmaceutical products for veterinary use, focused on animal health and welfare through innovative drug development and biopharmaceutical research.

1 investor